Administration of poly-D-glutamic acid induces proliferation of erythropoietin-producing peritubular cells in rat kidney

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 2, 2007, Pages

  Kishore, Bellamkonda K ^a,d   Isaac, Jorge ^b,c   Westenfelder, Christof ^a,d  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anemia; Fibroblasts; Immunohistochemistry; In situ hybridization; Proximal tubular cell

Indexed keywords

5' NUCLEOTIDASE; ALPHA SMOOTH MUSCLE ACTIN; ERYTHROPOIETIN; MESSENGER RNA; POLYGLUTAMIC ACID; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSIS; KIDNEY; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; LYSOSOME STORAGE DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 33846888817     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00034.2006     Document Type: Article

References (50)

1. Bachmann S, Le Hir M, Eckardt K. Co-localization of erythropoietin messenger RNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41: 335-341, 1993.
2. Burton C, Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27: 765-775, 1996.
3. Carlini R, Reyes A, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47: 740-745, 1995.
4. Dawson TP, Gandhi R, LeHir M, Kaissling B. Ecto-5′- nucletotidase: localization in rat kidney by light microscopic histochemical and immunohistochemical methods. J Histochem Cytochem 37: 39-47, 1989.
5. Donnelly S. Why erythropoietin is made in the kidney? The kidney functions as a critmeter. Am J Kidney Dis 38: 415-425, 2001.
6. Eddy AA. Interstitial nephritis induced by protein overload proteinuria. Am J Pathol 135: 719-733, 1989.
7. Eddy AA. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 49: D49-S54, 1996.
8. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000.
9. Eddy AA. Role of cellular infiltrates in response to proteinuria. Am J Kidney Dis 37: S25-S29, 2001.
10. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med 228: 1-14, 2003.
11. Gaedeke J, Peters H, Noble NA, Border WA. Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol 135: 153-160, 2001.
12. Gandhi R, Le Hir M, Kaissling B. Immunolocalization of ecto-5′-nucleotidase in the kidney by a monoclonal antibody. Histochemistry 95: 165-174, 1990.
13. Hay ED. Extracellular matrix, cell skeletons, and embryonic development. Am J Med Genet 34: 14-29, 1989.
14. Jellkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 18: 555-559, 1998.
15. Jelkmann W. Erythropoietin: structure, control of production and function. Physiol Rev 72: 449-489, 1992.
16. Johnson DW, Saunders HJ, Brew BK, Ganesan A, Baxter RC, Poronnik P, Cook DI, Gyory AZ, Filed MJ, Pollock CA. Human renal fibroblasts modulate proximal tubules cell growth and transport via the IGF-1 axis. Kidney Int 52: 1486-1496, 1997.
17. Kaissling B, Hegg I, Loffing J, Le Hir M. Morphology of interstitial cells in the healthy kidney. Anat Embryol 193: 303-318, 1996.
18. Kishore BK, Fuming S, Maldague P, Tulkens PM, Courtoy PJ. Mechanism of thesaurismosis and altered lysosomal dynamics induced by poly-D-glutamic acid in kidney proximal tubular cells. Lab Invest 74: 1025-1037, 1996.
19. Kishore BK, Isaac J, Fausther M, Tripp SR, Shi H, Gill PS, Braun N, Zimmermann H, Sévigny J, Robson SC. Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling. Am J Physiol Renal Physiol 288: F1032-F1043, 2005.
20. Kishore BK, Krane CM, Miller RL, Shi H, Zhang P, Hemmert A, Sun R, Nelson RD. P2Y2 receptor mRNA and protein expression is altered in inner medullas of hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function. Am J Physiol Renal Physiol 288: F1164-F1172, 2005.
21. Kishore BK, Kállay Z, Lambricht P, Laurent G, Tulkens PM. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. J Pharmacol Exp Ther 255: 867-874, 1990.
22. Kishore BK, Lambricht P, Laurent G, Maldague P, Wagner R, Tulkens PM. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phsopholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic, and poly-D-glutamic acids. J Pharmacol Exp Ther 255: 757-885, 1990.
23. Kishore BK, Maldague P, Tulkens PM, Courtoy PJ. Poly-D-glutamic acid induced an acute lysosomal thesaurismosis of proximal tubules and a marked proliferation of interstitium in rat kidney. Lab Invest 74: 1013-1023, 1996.
24. Koury S, Bondurant M, Koury M. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 71: 524-527, 1988.
25. Koury S, Koury M, Bondurant M, Caro J, Graber S. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization. Correlation with hematocrit, renal erythropoietin mRNA and serum erythropoietin concentration. Blood 74: 645-651, 1989.
26. Krantz S. Erythropoietin. Blood 77: 419-434, 1991.
27. Lacombe C, Mayeux P. The molecular biology of erythropoietin. Nephrol Dial Transplant 14: 22-28, 1999.
28. Laurent G, Maldague P, Toubeau G, Heuston-Stiennon JA, Tulkens PM. Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization. CRC Crit Rev Toxicol 19: 147-183, 1988.
29. Le Hir M, Kaissling B. Distribution of 5′-nucleotidase in the renal interstitium of the rat. Cell Tissue Res 258: 177-182, 1989.
30. Madewell BR. Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 15: 334-340, 2001.
31. Maxwell P, Ferguson LG, Nicholls LG, Johnson MH, Ratcliffe PJ. The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 52: 715-724, 1997.
32. Maxwell P, Osmond M, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJ, Johnson MH, Ratcliffe PJ. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44: 1149-1162, 1993.
33. Ribbatti D, Presta M, Vacca A, Rial R, Giulian R, Dell'Era P, Nico B, Roncali L, Dammacco F. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93: 2627-2636, 1999.
34. Schuster S, Koury S, Bohrer M, Salceda S, Caro J. Cellular sites of extra renal erythropoietin production in anaemic rats. Brit J Amatol 81: 153-159, 1992.
35. Schena FP. Cytokine network and resident renal cells in glomerular diseases. Nephrol Dial Transplant 14, Suppl 1: 22-26, 1999.
36. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322, 2000.
37. Sheikh-Hamad D, Cacini W, Buckley AR, Isaac J, Truong LD, Tsao CC, Kishore BK. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78: 147-155, 2004.
38. Takahashi T, Kakuno K, Yamada H, Endou H. Internephron distribution of purine-metabolizing enzymes in rats. Ren Physiol Biochem 12: 287-294, 1989.
39. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administration of mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-F42, 2005.
40. Tögel F, Isaac J, Hu Z, Weiss K, Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67: 1772-1784, 2005.
41. von Kooten C, Langers AMJ, Brujin JA, Daha MR. Role of tubular cells in progressive renal disease. Kidney Blood Press Res 22: 53-61, 1999.
42. Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol 10: 294-298, 2002.
43. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 58: 647-657, 2000.
44. Westenfelder C, Baranowski RL. Erythropoietin treatment ameliorates ischemic acute renal failure in rats by its anti-apoptotic, motogenic and mitogenic actions (Abstract). J Am Soc Nephrol 12: 793A, 2001.
45. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55: 808-820, 1999.
46. Westenfelder C, Joseph A, Swenson L, Isaac J, Baranowski RL.Dual roles of NFκB in ischemic acute renal failure in rats: (1) mediates maladaptive suppression of erythropoietin (EPO) gene, (2) mediates EPO's anti-apoptotic effects in proximal tubular cells (Abstract). Nephrol Dial Transpl 18: 384A, 2003.
47. Wolf G, Neilson EG. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39: 401-420, 1991.
48. Wu F, Li PL, Zou AP. Microassay of 5′-nucleotidase and adenosine deaminase in microdissected nephron segments. Anal Biochem 266: 133-139, 1999.
49. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF. Structure, function, and activation of the erythropoietin receptor. Blood 81: 2223-2236, 1993.
50. Zoja C, Benigni A, Remuzzi G. Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators. Exp Nephrol 7: 420-428, 1999.